The Medical Devices sector report, “Vagus Nerve Stimulators (VNS) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Vagus Nerve Stimulators (VNS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A Vagus Nerve Stimulator is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders such as epilepsy and depression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
A Vagus Nerve Stimulator is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders such as epilepsy and depression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to :
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Vagus Nerve Stimulators (VNS) - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Adriakaim Inc
- Bionics Institute
- Boston Scientific Corp
- DuoCure Ltd.
- ElectroCore Inc
- LivaNova PLC
- LivaNova USA Inc
- MicroTransponder Inc
- Neurive Inc
- Neuroloop Gmbh
- Nexeon MedSystems Inc
- Otto Bock HealthCare GmbH
- Purdue University
- ReShape Lifesciences Inc
- Setpoint Medical Corp
- Synergia Medical SA
- The Feinstein Institute for Medical Research
- Trifectas Medical Corp.
- tVNS Technologies GmbH
- University of Alabama
- University of Auckland
- University of Pittsburgh
- University of Wisconsin Madison
- West Virginia University